Five phase 3 trials presented at ESMO 2026 showed new options in small cell lung, bladder, prostate, KRAS G12C lung and ...
For patients with hairy cell leukemia whose cancer returns after multiple treatments, researchers are investigating whether ...
For people with lung or pancreatic cancer driven by changes in the KRAS gene, research presented at the 2026 European Society ...
Researchers are exploring new options for patients with relapsed or refractory hairy cell leukemia, including chimeric ...
Adding Imdelltra (tarlatamab) to Imfinzi (durvalumab) maintenance therapy helped people with extensive-stage small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results